A Study of SEA-CD40 Given With Other Drugs in Cancers

Clinical trial NCT04993677 · COMPLETED

Trial details

NCT number: NCT04993677
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Carcinoma, Non-Small- Cell Lung

Start date: 2021-10-06
Primary completion: 2024-01-03
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.